{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T18:04:44Z","timestamp":1794765884205,"version":"4.9.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Resuscitated out-of-hospital cardiac arrest (OHCA) patients who remain comatose after hospital arrival are at high risk of mortality due to anoxic brain injury. MicroRNA are small\u2013non-coding RNA molecules ultimately involved in gene-silencing. They show promise as biomarkers, as they are stable in body fluids. The microRNA 9-3p (miR-9-3p) is associated with neurological injury in trauma and subarachnoid haemorrhage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>This post hoc analysis considered all 171 comatose OHCA patients from a single centre in the target temperature management (TTM) trial. Patients were randomized to TTM at either 33\u00b0C or 36\u00b0C for 24\u2005h. MicroRNA-9-3p (miR-9-3p) was measured in plasma sampled at admission and at 28, 48, and 72\u2005h. There were no significant differences in age, gender, and pre-hospital data, including lactate level at admission, between miR-9-3p level quartiles. miR-9-3p levels changed markedly following OHCA with a peak at 48\u2005h. Median miR-9-3p levels between TTM 33\u00b0C vs. 36\u00b0C were not different at any of the four time points. Elevated miR-9-3p levels at 48\u2005h were strongly associated with an unfavourable neurological outcome [OR: 2.21, 95% confidence interval (CI): 1.64\u20133.15, P\u2009&amp;lt;\u20090.0001). MiR-9-3p was inferior to neuron-specific enolase in predicting functional neurological outcome [area under the curve: 0.79 (95% CI: 0.71\u20130.87) vs. 0.91 (95% CI: 0.85\u20130.97)].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>MiR-9-3p is strongly associated with neurological outcome following OHCA, and the levels of miR-9-3p are peaking 48 hours following cardiac arrest.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjacc\/zuac066","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T10:43:12Z","timestamp":1655116992000},"page":"609-616","source":"Crossref","is-referenced-by-count":8,"title":["MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrest"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5880-3733","authenticated-orcid":false,"given":"Rasmus Paulin","family":"Beske","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Bache","sequence":"additional","affiliation":[{"name":"Department of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"},{"name":"Centre for Genomic Medicine, Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Abild Stengaard Meyer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kj\u00e6rgaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bro-Jeppesen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital , Aarhus , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laust","family":"Obling","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Harboe","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rossing","sequence":"additional","affiliation":[{"name":"Centre for Genomic Medicine, Rigshospitalet , Copenhagen , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen : Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9829-1031","authenticated-orcid":false,"given":"Finn Cilius","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Centre for Genomic Medicine, Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen : Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences at Helsingborg, Lund University , Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-0981","authenticated-orcid":false,"given":"Christian","family":"Hassager","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Heart Centre, Copenhagen University Hospital - Rigshospitalet , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"2022080914485587600_zuac066-B1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.resuscitation.2008.09.017","article-title":"Post-cardiac arrest syndrome\u202f: epidemiology, pathophysiology, treatment, and prognostication A scientific statement from the international liaison committee on resuscitation\u202f; the American heart association emergency cardiovascular care committee\u202f; the council on cardiovascular surgery and anesthesia; the council on cardiopulmonary, perioperative, and critical care; the council on clinical cardiology; the council on stroke","author":"Nolan","year":"2008","journal-title":"Resuscitation"},{"key":"2022080914485587600_zuac066-B2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1007\/s00134-013-3043-4","article-title":"Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort","volume":"39","author":"Lemiale","year":"2013","journal-title":"Intensive Care Med"},{"key":"2022080914485587600_zuac066-B3","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.jacc.2015.03.538","article-title":"Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33\u00b0C and 36\u00b0C","volume":"65","author":"Stammet","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022080914485587600_zuac066-B4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00134-021-06368-4","article-title":"European Resuscitation council and European society of intensive care medicine guidelines 2021: post-resuscitation care","volume":"47","author":"Nolan","year":"2021","journal-title":"Intensive Care Med"},{"key":"2022080914485587600_zuac066-B5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/1756-0500-7-726","article-title":"Serum neuron specific enolase\u2014impact of storage and measuring method","volume":"7","author":"Rundgren","year":"2014","journal-title":"BMC Res Notes"},{"key":"2022080914485587600_zuac066-B6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/npp.2012.87","article-title":"General principals of miRNA biogenesis and regulation in the brain","volume":"38","author":"O\u2019Carroll","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"2022080914485587600_zuac066-B7","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/cc13753","article-title":"The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest","volume":"18","author":"Gilje","journal-title":"Crit Care"},{"key":"2022080914485587600_zuac066-B8","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.7150\/thno.19851","article-title":"Incremental value of circulating MiR-122-5P to predict outcome after out of hospital cardiac arrest","volume":"7","author":"Devaux","year":"2017","journal-title":"Theranostics"},{"key":"2022080914485587600_zuac066-B9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1802879","article-title":"Circulating levels of miR-574-5p are associated with neurological outcome after cardiac arrest in women: a target temperature management (TTM) trial substudy","author":"Boileau","journal-title":"Dis Markers"},{"key":"2022080914485587600_zuac066-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21124353","article-title":"Circulating levels of brain-enriched micrornas correlate with neuron specific enolase after cardiac arrest\u2014a substudy of the target temperature management trial","volume":"21","author":"Stefanizzi","year":"2020","journal-title":"International J Mol Sci"},{"key":"2022080914485587600_zuac066-B11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s12975-020-00793-1","article-title":"Elevated miR-9 in cerebrospinal fluid is associated with poor functional outcome after subarachnoid hemorrhage","volume":"11","author":"Bache","year":"2020","journal-title":"Transl Stroke Res"},{"key":"2022080914485587600_zuac066-B12","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1310519","article-title":"Targeted temperature management at 33\u00b0c versus 36\u00b0c after cardiac arrest","volume":"369","author":"Nielsen","year":"2013","journal-title":"N Engl J Med"},{"key":"2022080914485587600_zuac066-B13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ahj.2012.01.013","article-title":"Target temperature management after out-of-hospital cardiac arrest - A randomized, parallel-group, assessor-blinded clinical trial - rationale and design","volume":"163","author":"Nielsen","year":"2012","journal-title":"Am Heart J"},{"key":"2022080914485587600_zuac066-B14","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/CIR.0b013e3182340239","article-title":"Primary outcomes for resuscitation science studies\u202f: a consensus statement from the American heart association","volume":"124","author":"Becker","year":"2011","journal-title":"Circulation"},{"key":"2022080914485587600_zuac066-B15","article-title":"R Core Team. nlme: linear and nonlinear mixed effects models. R package version 3.1-157. 2022.","author":"Pinheiro"},{"key":"2022080914485587600_zuac066-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-017-0104-9","article-title":"Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke","volume":"5","author":"S\u00f8rensen","year":"2017","journal-title":"Biomark Res"},{"key":"2022080914485587600_zuac066-B17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/ijms22041563","article-title":"Plasma miR-9-3p and miR-136-3p as potential novel diagnostic biomarkers for experimental and human mild traumatic brain injury","volume":"22","author":"Das","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2022080914485587600_zuac066-B18","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2147\/NDT.S290237","article-title":"Microrna-9-3p aggravates cerebral ischemia\/reperfusion injury by targeting fibroblast growth factor 19 (Fgf19) to inactivate gsk-3\u03b2\/nrf2\/are signaling","volume":"17","author":"Zhou","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2022080914485587600_zuac066-B19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0300891619867836","article-title":"Invisible hemolysis in serum samples interferes in NSE measurement","volume":"106","author":"Mastroianni","year":"2020","journal-title":"Tumori"},{"key":"2022080914485587600_zuac066-B20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-94-017-7215-0_16","article-title":"Non coding RNA molecules as potential biomarkers in breast cancer 2015","volume":"867","author":"De Leeneer","journal-title":"Adv Exp Med Biol"},{"key":"2022080914485587600_zuac066-B21","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1523\/JNEUROSCI.0630-16.2016","article-title":"The brain-enriched microRNA miR-9-3p regulates synaptic plasticity and memory","volume":"36","author":"Sim","year":"2016","journal-title":"J Neurosci"}],"container-title":["European Heart Journal. Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/11\/8\/609\/45295450\/zuac066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/11\/8\/609\/45295450\/zuac066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:49:38Z","timestamp":1660056578000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/11\/8\/609\/6606171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2022,8,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuac066","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,6,13]]}}}